Dalençon François
Discovery Department; Sanofi Pasteur; Campus Mérieux; Marcy l'Etoile, France.
Hum Vaccin Immunother. 2013 Sep;9(9):2013-4. doi: 10.4161/hv.26074. Epub 2013 Aug 12.
The Session 9 of the Modern Vaccine Adjuvant/Formulation meeting pointed out the permanent need for vaccine improvement and for adjuvant development. Indeed, the increasing use of recombinant subunit vaccines for both parenteral and mucosal vaccination necessitates the development of improved adjuvants. This session dealt with strategies for the development of new vaccine adjuvants with respect to the availability of new molecules targeting specifically the receptors of the systemic or mucosal immune system.
现代疫苗佐剂/制剂会议第九场会议指出，疫苗改进和佐剂研发一直是必要的。事实上，重组亚单位疫苗在注射和黏膜疫苗接种中的使用日益增加，这就需要研发改良佐剂。本次会议讨论了针对专门作用于全身或黏膜免疫系统受体的新分子，开发新型疫苗佐剂的策略。
